A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors
Wagner, A.J., Kindler, H., Gelderblom, H., Schöffski, P., Bauer, S., Hohenberger, P., Kopp, H.-G., Lopez-Martin, J.A., Peeters, M., Reichardt, P., Qin, A., Nippgen, J., Ilaria, R.L., Rutkowski, P.
Published in Annals of oncology (01.03.2017)
Published in Annals of oncology (01.03.2017)
Get full text
Journal Article
Retrospective RAS analysis of the EPIC trial: Cetuximab plus irinotecan vs irinotecan in patients (pts) with second-line metastatic colorectal cancer (mCRC)
Sobrero, A, Lenz, H-J, Eng, C, Scheithauer, W, Middleton, G, Chen, W, Esser, R, Nippgen, J, Burris, H
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
591P - Impact of primary tumour side on 3-year survival outcomes of first-line (1L) FOLFOX-4 ± cetuximab in patients with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in the phase III TAILOR trial
Qin, S., Liu, T., Xu, J., Li, Q., Cheng, Y., Nippgen, J., Chen, W., Li, J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
591PImpact of primary tumour side on 3-year survival outcomes of first-line (1L) FOLFOX-4 ± cetuximab in patients with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in the phase III TAILOR trial
Qin, S, Liu, T, Xu, J, Li, Q, Cheng, Y, Nippgen, J, Chen, W, Li, J
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Impact of primary tumour side on 3-year survival outcomes of first-line (1L) FOLFOX-4 ± cetuximab in patients with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in the phase III TAILOR trial
Qin, S., Liu, T., Xu, J., Li, Q., Cheng, Y., Nippgen, J., Chen, W., Li, J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
484PRetrospective RAS analysis of the EPIC trial: Cetuximab plus irinotecan vs irinotecan in patients (pts) with second-line metastatic colorectal cancer (mCRC)
Sobrero, A, Lenz, H-J, Eng, C, Scheithauer, W, Middleton, G, Chen, W, Esser, R, Nippgen, J, Burris, H
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Correlation of KRAS status (wild type [wt] vs. mutant [mt]) with efficacy to first-line cetuximab in a study of cetuximab single agent followed by cetuximab + FOLFIRI in patients (pts) with metastatic colorectal cancer (mCRC)
Cervantes, A., Macarulla, T., Martinelli, E., Rodriguez-Braun, E., Ciardiello, F., Stroh, C., Nippgen, J., Baselga, J., Tabernero, J.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Expression of Ki‐67 in squamous cell carcinoma of the penis
Berdjis, Navid, Meye, Axel, Nippgen, Johannes, Dittert, Dag, Hakenberg, Oliver, Baretton, Gustavo B., Wirth, Manfred P.
Published in BJU international (01.07.2005)
Published in BJU international (01.07.2005)
Get full text
Journal Article
Relationship of efficacy with KRAS status (wild type versus mutant) in patients with irinotecan-refractory metastatic colorectal cancer (mCRC), treated with irinotecan (q2w) and escalating doses of cetuximab (q1w): The EVEREST experience (preliminary data)
Tejpar, S., Peeters, M., Humblet, Y., Vermorken, J. B., De Hertogh, G., De Roock, W., Nippgen, J., von Heydebreck, A., Stroh, C., Van Cutsem, E.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
KRAS status and efficacy of first-line treatment of patients with metastatic colorectal cancer (mCRC) with FOLFOX with or without cetuximab: The OPUS experience
Bokemeyer, C., Bondarenko, I., Hartmann, J. T., De Braud, F. G., Volovat, C., Nippgen, J., Stroh, C., Celik, I., Koralewski, P.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Phase I/IIa trial of cilengitide (EMD121974) and temozolomide with concomitant radiotherapy, followed by temozolomide and cilengitide maintenance therapy in patients (pts) with newly diagnosed glioblastoma (GBM)
Stupp, R., Goldbrunner, R., Neyns, B., Schlegel, U., Clement, P., Grabenbauer, G. G., Hegi, M. E., Nippgen, J., Picard, M., Weller, M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial
Van Cutsem, E., Nowacki, M., Lang, I., Cascinu, S., Shchepotin, I., Maurel, J., Rougier, P., Cunningham, D., Nippgen, J., Köhne, C.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Cetuximab with irinotecan in first-line treatment of epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer (mCRC): Preliminary safety results (CRYSTAL)
Lang, I., Zaluski, J., Changchien, C. R., Makhson, A., Pinter, T., D’Haens, G., Lim, R., Nippgen, J., Van Cutsem, E.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
An open-label, phase I study of cetuximab to assess the safety, efficacy and pharmacokinetics (PK) of different cetuximab regimens in patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer (mCRC)
Humblet, Y., Peeters, M., Bleiberg, H., Stupp, R., Sessa, C., Roth, A., Nippgen, J., Nolting, A., Stuart, P., Giaccone, G.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
864Results of chemotherapy with cisplatin, bleomycin and methotrexate for advanced squamous cell carcinoma of the penis
Hakenberg, O., Nippgen, J., Zastrow, S., Oehlschläger, S., Schrödter, S., Wirth, M.
Published in European urology supplements : official journal of the European Association of Urology (01.03.2005)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2005)
Get full text
Journal Article